Jackson Library

• Admissions
• Faculty & Research
• Alumni |
• Recruiters & Companies |
• News |
• About the GSB

• Articles, Books, Databases, etc.
  • Databases
  • Library Catalogs
  • eJournals
  • eBooks
  • Cases & Research Papers
  • Business Web Sites
  • Hot Topics
• Research Guides
  • Where can I find ...
  • Video Tutorials
• Class Support
  • Class Guides
  • Course Reserve
• Services
  • Help
• Library Information
  • About the Library
  • Borrowing & Access
  • Contact
  • News
• Event & Program Support

 

• Ask a Librarian
• Suggestions
• Hours
  
• Site Index

• Email
• Print
• Share

MGTECON 332/Health Research and Policy 392/Medical Information Science 432: Analysis of Costs, Risks and Benefits of Health Care

Required text:
Methods for the economic evaluation of health care programmes, 3rd ed., by Drummond, Sculpher, Torrance, O'Brien, and Stoddart, Oxford University Press, 2005
Jackson Library: 1 copy on Reserve
Lane Medical Library: RA410.5.D77 2005

Recommended texts:
Cost-Effectiveness in Health and Medicine, by Gold, Siegel, Russell, and Wenstein, Oxford University Press, 1996
Jackson Library: 2 copies on Reserve
Lane Medical Library: RA410.5 .C688 1996

Health Economics, 4th ed., ed by Phelps, Addison-Wesley, 2009.
Jackson Library: 1 copy on Reserve

Reading assignments by lecture topics:

• Introduction
• Basic Approach to Cost Effectiveness and Cost-Benefit Analysis in Health Care
• Decision Analysis
• Introduction to Markov and Related Modeling Techniques
• Valuing Output I: Quality-Adjusted Life Years (QALYs), Patient Preferences, and Outcomes
• Valuing Output II: Human Capital and Contingent Valuation
• Cost Finding
• Evaluating Efficacy
• Diagnosis of Coronary Artery Disease
• Probabilistic Sensitivity Analysis and Modeling
• HIV Detection Strategies
• Vaccine Development: Value and Incentives
• Economics of Genomics
• Evaluation in Kaiser-Permanente
• Pharmaceutical Industry Perspective on CEA

Related Link: Stanford Health Care Club

 

Introduction

Fuchs VR, Garber AM. The new technology assessment. New England Journal of Medicine, 1990; 323:673-677 (Syllabus, 5pp.).

Drummond: Chapters 1 and 2, pp. 1-26 (Text, 26 pp.)

Singer P. Why We Must Ration Health Care. The New York Times, July 19 2009 (Online, 8pp.)

Optional Reading:

Garber, AM, Skinner, J: Is American Health Care Uniquely Inefficient? Journal of Economic Perspectives, 2008; 22(4): 27-50. View article

Gold: Chapter 1, pp. 3-24 (Text, 21 pp.)

Basic Approach to Cost Effectiveness and Cost-Benefit Analysis in Health Care

Enthoven AC, Garber AM: Economic Analysis of Health and Medical Technologies ad Practices, and other Public Programs. An Overview Outline. (Syllabus, 27 pp.)

Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. Journal of the American Medical Association, 1996; 276: 1253-1258 (Syllabus, 6 pp.)

Drummond: Chapter 3, sections 3.1-3.3 pp. 27-48 (Text, 22 pp.), Chapter 5, pp. 103-136 (Text, 34 pp.), Chapter 6, sections 6.1-6.2, pp. 137-147 (Text, 11 pp.) and Chapter 7, section 7.1, pp. 211-215 (text, 5 pp.)

Gold: Chapter 8, pp. 247-271 (Text, 25 pp.)

Optional reading:
Garber AM. Advances in cost-effectiveness analysis of health interventions, Chapter 4, pp. 181-221, in Culyer AJ, Newhouse JP, eds., Handbook of Health Economics, Volume 1A, Amsterdam: Elsevier Science B.V., 2000. (On reserve, 40 pp.)
* This chapter gives an overview of recent developments in cost-effectiveness analysis. It includes technical material written at the graduate economics level.

Decision Analysis

Owens DK, Soc HC: Biomedical Decision Making: Probabilistic Clinical Reasoning. Chapter 3, pages 80-132 in Shortliffe and Cimino, eds., Biomedical Informatics: Computer Applications in Health Care and Biomedicine, 3rd edition. New York: Springer, 2006 (Syllabus, 52 pp.)
View article

Sculpher M, Fenwick E, Claxton K. Assessing Quality in Decision Analytic Cost-Effectiveness Models: A Suggested Framework and Example of Application. PharmacoEconomics, 2000; 17(5): 461-477.
View article

Optional reading:

Detsky, AS, Naglie G, Krahn MD, Naimark D, Redelmeier DA. Primer on medical decision analysis: Part 1- Getting started. Medical Decision Making, 1997; 17:123-125.
View article

Detsky AS, Naglie G, Krahn MD, Redelmeier DA, Naimark D. Primer on medical decision analysis: Part 2- Building a tree. Medical Decision Making, 1997; 17:126-135.
View article

Naglie G, Krahn MD, Naimark D, Redelmeier DA, Detsky AS. Primer on medical decision analysis: Part 3- Estimating probabilities and utilities. Medical Decision Making, 1997; 17:136-141.
View article

Krahn MD, Naglie G, Naimark D, Redelmeier DA, Detsky AS. Primer on medical decision analysis: Part 4- Analyzing the model and interpreting the results. Medical Decision Making, 1997; 17: 142-151.
View article

Introduction to Markov and Related Modeling Techniques

Sonnenberg F, Beck R. Markov models in Medical Decision Making: A Practical Guide. Medical Decision Making, 1993; 13 (4): 322-338 (Syllabus, 17 pp.)

Optional reading:
Naimark D, Krahn MD, Naglie G, Redelmeier DA, Detsky AS. Primer on medical decision analysis: Part 5- Working with Markov processes. Medical Decision Making, 1997; 178:152-159.
View article

Valuing Output I: Quality-Adjusted Life Years (QALYs), Patient Preferences, and Outcomes

Tengs TO, Wallace A. One Thousand Health-Related Quality-of-Life Estimates. Medical Care, 2000; 38(6):583-637.
View article

Bell CM, Chapman RH, Stone PW, Sadberg EA, Neuman PJ. An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analysis. Medical Decision Making, 2001; 21:288-294.
View article

Drummond: Chapter 6, Sections 6.3 to en of chapter, p. 147-196 (Text, 50 pp.)
* After reading this chapter, please examine Tables 6.10 and6.11 and read the instructions for determining your Health Utilities Index mark3 classification score. At noon the day before class please measure your quality of well being.

Optional reading:

Gold: Chapter 4,pp. 82-134 (Text, 52 pp.)

Valuing Output II

Drummond: Chapter 7, review section 7.1 and read the rest of the chapter, pp. 211-240 (Text, 30 pp.)

Optional reading:

Gold: Chapter 2, pp. 25-53 (Text, 28 pp.)

Schelling TC: The life you save may be your own. In SB Chase (Ed.) Problems in Public Expenditure Analysis, Brookings, Washington, 1968 (On reserve, 35 pp.)

Cost Finding

Drummond: Chapter 4, pp. 55-101 (Text, 47 pp.)

Optional reading:

Gold: Chapter 6, pp. 176-213 (Text, 37 pp.)

Evaluating Efficacy

U.S. Preventive Services Task Force, Guide to Clinical Preventive Services, 2nd edition, 1996, Methodology, pp. xxxix-lx (Syllabus, 9 pp.) Online version of updated methodology (Excerpt in syllabus, 14 pp.)

Enthoven AC: Part I--Overview of Technology Assessment and Research Designs, and Part II--An Introductory Overview of Selected Research Designs (Syllabus, 32 pp.)

Optional reading:

Phelps C. The methodologic foundations of studies of the appropriateness of medical care. New England Journal of Medicine, 1993; 329:1241-5.
View article

Gold: Chapter 3, p. 54-81 (Text, 27 pp.)

Diagnosis of Coronary Artery Disease

Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Annals of Internal Medicine, 1999; 130(9):719-728.
View article

Probabilistic Sensitivity Analysis and Modeling

Briggs AH, Goeree R, Blackhouse G, and O'Brien, B. Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease. Medical Decision Making, 2002; 22: 290-308
View article

Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J and O'Hagan T. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Economics, 2005; 14: 339-347
View article

Optional reading:

Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Economics, 2001 Dec;10(8):779-8
View article

HIV Detection Strategies

Sanders GD, Bayoumi AM, SundaramV, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK. Cost effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New England Journal of Medicine, 2005; 352(6): 570-85
View article

Owens DK, Harris RA, Scott P, Nease RF: Screening surgeons for HIV infection: a cost-effectiveness analysis. Annals of International Medicine, 1995; 122:641-652
View article

Optional reading:
Qaseem A, Snow V, Shekelle P, Hopkins R, Owens DK, for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians.  Screening for HIV in health care settings: A guidance statement from the American College of Physicians.  Annals of Internal Medicine 2009; 150:125-131
View article

Vaccine Development: Value and Incentives

43 Ways to Save the World. The Economist, July 2 2005; 376(8433): 69-70
View article

Economics of Genomics

Evaluation in Kaiser-Permanente

Levine S., Campen D., Millares M., Barrueta A. Kaiser Permanente's prescription drug benefit. Health Affairs, 2000; 19(2): 185-190
View article

Garber AM, Cost-effectiveness and evidence evaluation as criteria for coverage policy. Health Affairs, 2004; Web Exclusive W4-284-W4-296
View article

Pharmaceutical Industry Perspective on CEA

Optional reading:
Sharpe P, Keelin T. How SmithKline Beecham Makes Better Resource-Allocation Decisions. Harvard Business Review, March-April 1998:76(2):45-57
View article

Pharmacoeconomic Guidelines Around the World

From International Society for Pharmacoeconomics & Outcomes Research.

 

GSB Network     Stanford Network     Special Password

 

 

• Back to Top